JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2001; 37:386-391
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, V.
Right arrow Articles by Maisel, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, V.
Right arrow Articles by Maisel, A.

A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study

Van Cheng, BS*, Radmila Kazanagra, MD*, Alex Garcia, LVN*, Leslie Lenert, MD* {dagger}, Padma Krishnaswamy, MD*, Nancy Gardetto, NP*, Paul Clopton, BS* and Alan Maisel, MD, FACC* {dagger}

* Division of Cardiology, Veteran’s Affairs Medical Center, San Diego, California, USA
{dagger} Department of Medicine, University of California, San Diego, California, USA



View larger version (26K):

[in a new window]
 
Figure 1 B-type natriuretic peptide levels and NYHA classification before and after treatment in relation to end points or no end points (successful treatment). Each value represents mean ± SEM and is analyzed by analysis of variance. BNP = B-type natriuretic peptide; NYHA = New York Heart Association.

 


View larger version (17K):

[in a new window]
 
Figure 2 The relation between end points and rising versus falling BNP levels during treatment. Values are given as percentages and analyzed by chi-square analysis. BNP = B-type natriuretic peptide (p < 0.001).

 


View larger version (30K):

[in a new window]
 
Figure 3 Receiver operating characteristic curves for patients with decompensated congestive heart failure compares the sensitivity and specificity of BNP measurements to 30-day readmission rates. Discrete cut-points are labeled. The AUC (C-statistic) was 0.72 for readmission. Sensitivity, specificity, positive and negative predictive values and accuracy are recorded for each cut-point of the receiver operating characteristic curve. AUC = area under the curve; BNP = B-type natriuretic peptide.

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2001 by the American College of Cardiology Foundation.